These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 23744815

  • 41. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
    Shibata M, Yanaga K, Morizane T, Yanagawa T, Hirakawa M, Ueno Y, Esquivel CO, Mitamura K.
    J Gastroenterol; 2003; 38(6):598-602. PubMed ID: 12858850
    [Abstract] [Full Text] [Related]

  • 42. Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma.
    Corradini SG, Burza MA, Molinaro A, Romeo S.
    Hepatology; 2011 May; 53(5):1776; author reply 1777. PubMed ID: 21351112
    [No Abstract] [Full Text] [Related]

  • 43. Viral pathogenesis of hepatocellular carcinoma in the United States.
    Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER.
    Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256
    [Abstract] [Full Text] [Related]

  • 44. Delayed recurrence of hepatocellular carcinoma after liver transplantation: detection of origin by chromosomal analysis.
    Al-Joundi T, Gibson S, Brunt EM, Shakil O, Lee RS, Di Bisceglie AM.
    Liver Transpl; 2000 May; 6(3):374-5. PubMed ID: 10827244
    [Abstract] [Full Text] [Related]

  • 45. Donor origin de novo HCC in a noncirrhotic liver allograft 3 years after liver transplantation.
    Vernadakis S, Poetsch M, Weber F, Treckmann J, Mathe Z, Baba HA, Paul A, Kaiser GM.
    Transpl Int; 2010 Mar 01; 23(3):341-3. PubMed ID: 19737373
    [No Abstract] [Full Text] [Related]

  • 46. Treatment of hepatocellular carcinoma with liver transplantation: a single-center experience from Brazil.
    Teixeira AC, Mente ED, Castro-e-Silva O, Sankarankutty AK, Cantão CA, Souza FF, Abud D, Muglia V, Elias-Junior J, Martinelli AL.
    Transplant Proc; 2010 Mar 01; 42(2):502-4. PubMed ID: 20304177
    [Abstract] [Full Text] [Related]

  • 47. [HCV infection among cirrhotic patients as a risk factor for generation of hepatocellular carcinoma: preliminary report].
    Kobayashi S, Nagai Y, Nakao T, Nogami H, Isono K.
    Nihon Geka Gakkai Zasshi; 1991 Nov 01; 92(11):1666. PubMed ID: 1722866
    [No Abstract] [Full Text] [Related]

  • 48. [Incidence of hepatocellular carcinoma in patients treated with interferon].
    Yokosuka O, Omata M.
    Nihon Rinsho; 1995 Sep 01; 53 Suppl(Pt 1):805-9. PubMed ID: 7563880
    [No Abstract] [Full Text] [Related]

  • 49. [Hepatitis C virus-related hepatocellular carcinoma].
    Sumi H, Yokosuka O.
    Nihon Rinsho; 2001 Oct 01; 59 Suppl 6():440-5. PubMed ID: 11761989
    [No Abstract] [Full Text] [Related]

  • 50. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation.
    Stangou AJ, Heaton ND, Hawkins PN.
    N Engl J Med; 2005 Jun 02; 352(22):2356. PubMed ID: 15930432
    [No Abstract] [Full Text] [Related]

  • 51. [Treatment of small hepatocarcinoma, complicating cirrhosis, by total resection of the liver and transplantation].
    Kestens PJ, Otte JB, Gigot JF, de Hemptinne B, Reynaert M, Raat A, Haot J, Schieroni R, Salizzoni M.
    Ann Chir; 1989 Jun 02; 43(10):791-96; discussion 796-8. PubMed ID: 2559647
    [No Abstract] [Full Text] [Related]

  • 52. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N, Rizzetto M.
    Minerva Gastroenterol Dietol; 2005 Mar 02; 51(1):31-46. PubMed ID: 15756144
    [Abstract] [Full Text] [Related]

  • 53. [Recurrence of hepatocellular carcinoma associated with hepatitis C virus after tumor ablation].
    Sakaguchi K, Kobayashi Y, Matsumoto E, Shiratori Y.
    Nihon Rinsho; 2004 Jul 02; 62 Suppl 7(Pt 1):629-33. PubMed ID: 15359874
    [No Abstract] [Full Text] [Related]

  • 54. [High risk group of patients with hepatitis C virus infection developing hepatocellular carcinoma].
    Yokosuka O, Omata M.
    Nihon Naika Gakkai Zasshi; 1995 Dec 10; 84(12):1975-9. PubMed ID: 8586916
    [No Abstract] [Full Text] [Related]

  • 55. Does hepatitis C virus cause hepatocellular carcinoma?
    Blum HE.
    Hepatology; 1994 Jan 10; 19(1):251-5. PubMed ID: 8276363
    [No Abstract] [Full Text] [Related]

  • 56. High frequency of antibodies to the hepatitis C virus among patients with hepatocellular carcinoma.
    Vargas V, Castells L, Esteban JI.
    Ann Intern Med; 1990 Feb 01; 112(3):232-3. PubMed ID: 2153357
    [No Abstract] [Full Text] [Related]

  • 57. [Hepatocellular carcinoma associated with alcoholic liver diseases].
    Yamagishi Y, Ebinuma H, Saito H, Ishii H.
    Nihon Rinsho; 2001 Oct 01; 59 Suppl 6():450-4. PubMed ID: 11761992
    [No Abstract] [Full Text] [Related]

  • 58. Osteopontin levels in patients with hepatitis C virus-related hepatocellular carcinoma.
    Filik L.
    Arch Med Res; 2011 May 01; 42(4):334; author reply 335. PubMed ID: 21820614
    [No Abstract] [Full Text] [Related]

  • 59. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma.
    De Vita S, Zagonel V, Russo A, Rupolo M, Cannizzaro R, Chiara G, Boiocchi M, Carbone A, Franceschi S.
    Br J Cancer; 1998 Jun 01; 77(11):2032-5. PubMed ID: 9667688
    [Abstract] [Full Text] [Related]

  • 60. Statins may protect against hepatocellular carcinoma development in patients infected with hepatitis C virus, but what are the mechanisms?
    Clément S, Peyrou M, Foti M, Negro F.
    J Clin Oncol; 2013 Nov 10; 31(32):4160-1. PubMed ID: 24081939
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.